David Michael Isserman - Net Worth and Insider Trading

David Michael Isserman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Michael Isserman owns 1 companies in total, including Nutra Pharma Corp (NPHC) .

Click here to see the complete history of David Michael Isserman’s form 4 insider trades.

Insider Ownership Summary of David Michael Isserman

Ticker Comapny Transaction Date Type of Owner
NPHC Nutra Pharma Corp 2010-02-11 Chief Marketing Officer

David Michael Isserman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Michael Isserman Ownership Network

Ownership Network List of David Michael Isserman

No Data

Ownership Network Relation of David Michael Isserman

Insider Network Chart

David Michael Isserman Owned Company Details

What does Nutra Pharma Corp do?

Who are the key executives at Nutra Pharma Corp?

David Michael Isserman is the Chief Marketing Officer of Nutra Pharma Corp. Other key executives at Nutra Pharma Corp include Chief Executive Officer Rik J Deitsch , other: Former CFO Bruno Sartori , and director & President - ReceptoPharm Harold Henry Rumph .

Nutra Pharma Corp (NPHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nutra Pharma Corp (NPHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nutra Pharma Corp (NPHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nutra Pharma Corp (NPHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nutra Pharma Corp Insider Transactions

No Available Data

David Michael Isserman Mailing Address

Above is the net worth, insider trading, and ownership report for David Michael Isserman. You might contact David Michael Isserman via mailing address: 2776 University Drive, Coral Springs Fl 33065.

Discussions on David Michael Isserman

No discussions yet.